aica ribonucleotide has been researched along with Hyperplasia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Liu, G; Wu, Y; Yang, M; Zhu, C | 1 |
1 other study(ies) available for aica ribonucleotide and Hyperplasia
Article | Year |
---|---|
5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside reduces intimal hyperplasia of tissue engineering blood vessel by inhibiting phenotype switch of vascular smooth muscle cell.
Topics: Aminoimidazole Carboxamide; Animals; Bioprosthesis; Blood Vessel Prosthesis; Carotid Arteries; G1 Phase; Hyperplasia; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Rats; Rats, Sprague-Dawley; Ribonucleotides; Stents; Tissue Engineering | 2017 |